 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
CORTEX PHARM INC, (COR) Stock Rating Learn More
| Our Overall Rating on CORTEX PHARM INC, COR is Not Available | | Cortex Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The company develops a pharmacology that modulates AMPA-type glutamate receptors, a complex of proteins that is involved in communication between nerve cells in the human brain. The companys product family, AMPAKINE compounds, is used in correcting neurological and psychiatric diseases, as well as disorders that involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter. Cortex was organized in 1987 and is based in Irvine, California. | | Our Not Available Rating on COR was issued on 11/21/2008 |
CORTEX PHARM INC Technical Rating
|
|
|
|
